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Abstract
It has been recognized that obese individuals are intrinsically in a state of chronic inflammation, as 
indicated by positive correlations between serum levels of C-reactive protein (CRP) and various 
anthropometric measures of obesity. To explore the hypothesis that a gene(s) may underlie this 
relationship, we conducted bivariate linkage analyses of BMI and CRP in white and African-
American (AA) families of the National Heart, Lung, and Blood Institute (NHLBI) Family Heart 
Study (FHS). Variance components linkage analysis as implemented in SOLAR was performed in 
1,825 whites (840 men and 985 women) and 548 AAs (199 men and 351 women). CRP exhibited 
significant genetic correlations with BMI in women (0.54 ± 0.10 for white and 0.53 ± 0.14 for 
AA) and the combined samples (0.37 ± 0.09 for white and 0.56 ± 0.13 for AA), but not in men. 
We detected a maximum bivariate lod score of 3.86 on chromosome 12q24.2–24.3 at 139 cM and 
a suggestive linkage signal (lod = 2.19) on chromosome 19p13.1 (44 cM) in white women. Both 
bivariate peaks were substantially higher than their respective univariate lods at the same locus for 
each trait. No significant lod scores were detected in AAs. Our results indicate that chromosome 
12q may harbor quantitative trait loci (QTLs) jointly regulating BMI and CRP in white women.
Correspondence: Ingrid B. Borecki (iborecki@wustl.edu). 
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at http://www.nature.com/oby
DISCLOSURE
The authors declared no conflict of interest.
HHS Public Access
Author manuscript
Obesity (Silver Spring). Author manuscript; available in PMC 2016 July 27.
Published in final edited form as:














Atherosclerosis often leads to ischemia or infarction of the heart, brain, kidney, and other 
organs. Obesity has been classified as one of the major risk factors for the development of 
atherosclerosis (1). Recent studies have also demonstrated that atherosclerosis is intrinsically 
a chronic inflammatory response of the vessel wall, characterized by the accumulation of 
leukocytes, especially macrophages and T cells (2). The concept of inflammation in relation 
to obesity was first reported by Hotamisligil et al. with a seminal publication in 1993 (ref. 
3). They presented that the expression of the tumor necrosis factor-α is markedly increased 
in adipocytes of obese animals. It was supported by the evidence that the human adipocytes 
and adipose tissue constitutively express tumor necrosis factor-α, and its expression of tumor 
necrosis factor-α falls markedly after weight loss (4). Adipose tissue is now recognized as 
the second only to lymphatic tissue in the secretion of signaling molecules including the 
proinflammatory cytokines, such as C-reactive protein (CRP) (5). The release of the 
inflammatory mediators from adipose tissue in persons with excess body fat may induce 
chronic inflammation. CRP is a critical inflammation cytokine which can be used as a 
sensitive marker for systemic inflammation. In addition, it has been shown that circulating 
concentrations of CRP are related to the anthropometric measures of obesity (6,7). One 
possible explanation could be that the innate immune system shares genetic effects 
(pleiotropy) with obesity.
The genetic contribution to obesity has been investigated extensively in several populations. 
The heritability of BMI was estimated as varying from 20 to 80% (8–10). The levels of CRP 
were also described to be influenced by a substantial degree of genetic effect. The relative 
contribution of additive genetic variance to baseline CRP was estimated as 40% in whites 
(11), which agrees with another report by Vickers et al. (12). Higher heritability of CRP 
(46%) was observed in American Indians (13), while a lower estimation (20%) was observed 
in a study for the elderly twins (14). One study in African Americans (AAs) suggested that 
CRP was ~38% heritable in hypertensive sibships (15).
Although publications have demonstrated that CRP phenotypically correlated with obesity, 
only one publication has reported on their genetic correlation to our knowledge. A 
significant genetic correlation was found between CRP and BMI using 349 white families 
randomly recruited in the National Heart, Lung, and Blood Institute (NHLBI) Family Heart 
Study (FHS), a subset sample of the present study (16). In the present study, we hypothesize 
that there exists potential gene(s) influencing both levels of inflammation marker CRP and 
BMI. To test this hypothesis, we estimated genetic correlation and conducted bivariate 
linkage analyses by gender for BMI and CRP of all white and AA subjects genotyped in the 
NHLBI FHS.
 METHODS AND PROCEDURES
 Study population
The NHLBI FHS is a multicenter, population-based study to identify and evaluate genetic 
and nongenetic determinants of coronary heart disease, atherosclerosis, and cardiovascular 
disease risk factors. Details on the design and methods of the study have been published 
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(17). In brief, 1,245 families in the study had been chosen randomly (random group) or on 
the basis of a higher than expected risk of CAD (high-risk group) from previously 
established population-based cohort studies in 1994–1995. A total of 5,381 members of 
these families completed an extensive clinical evaluation, including a detailed medical and 
lifestyle history. Subjects were recruited from: Framingham, MA; Minneapolis, MN; Salt 
Lake City, UT; Forsyth County, NC. The majority subjects in the study are whites in this 
period.
In 2002–2003, 2,754 whites were selected from 511 large, informative pedigrees, of which 
2,089 participants have been typed for genome-wide microsatellite markers. They were 
followed up in a clinical examination that included measurements of inflammation markers 
and anthropometry. In addition, 215 AA families (633 individuals) were also recruited in 
Birmingham, AL. They were previously examined by the Hypertension Epidemiology 
Network (HyperGEN), a multicenter study of the genetics of hypertension (18). The current 
analyses are based on 1,825 whites and 548 AAs who have been genotyped in the NHLBI 
FHS. All phenotypic data were obtained at the follow-up examination. We had excluded 264 
whites and 95 AAs from the main analyses for the following reasons: (i) missing data on 
CRP or BMI (n = 64), (ii) fasting time <10 h (n = 68); (iii) self-reported rheumatoid arthritis 
or autoimmune diseases (n = 227). The present study included 401 sibling pairs among 840 
men, 494 sibling pairs among 985 women, and 1,741 sibling pairs in combined white 
sample. The maximum number of sibling pairs per white family was 15 in women and men, 
and 45 in combined sample. In AA families, there were 52 men sibling pairs (n = 199), 142 
women sibling pairs (n = 351), and 355 sibling pairs in combined sample. The maximum 
number per family was 21, 10, and 66, respectively. Each participant gave informed consent, 
and the study protocol was reviewed and approved by each of the participating institutions.
 Measurements of phenotypes
Anthropometric measurements were collected with subjects wearing scrub suits. BMI was 
subsequently calculated as weight in kilograms divided by height in meters squared. Serum 
CRP was assayed at the University of Vermont with a high-sensitivity assay (BNII 
nephelometer (N High Sensitivity CRP; Dade Behring, Deerfield, IL)) with intra-assay 
coefficients of variation ranging from 2.3 to 4.4% and inter-assay coefficients of variation 
ranging from 2.1 to 5.7%.
 Genotypes for preliminary linkage analysis
All 1,825 white subjects were typed for 402 microsatellite markers by the NHLBI FHS at 
the National Institutes of Health Mammalian Genotyping Service (Marshfield, WI). In 
addition, 613 whites enriched for coronary heart disease risk factors were typed for 243 
autosomal STR markers by the Utah Molecular Genetics Laboratory. For 548 AA subjects, 
389 microsatellite markers were genotyped in Human Genetics Center of University of 
Texas at Houston. Detailed information on all measurements, genotype data, and quality 
control are available on the NHLBI FHS website (https://dsgweb.wustl.edu/fhscc/). At a 
significance level of 0.05, we can achieve 0.80 of power to detect locus-specific heritabilities 
as low as ~12% using univariate linkage analysis (see Supplementary Methods and 
Procedures online).
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The logarithmic transformation was used to approximately normalize the distributions of 
CRP. Both CRP and BMI were then adjusted in the mean and the variance for the covariate 
effects of age, age2, age3, and the field center, retaining only the terms significant at the 5% 
level. The adjusted variables were finally standardized for further linkage analyses to a mean 
of 0 and a standard deviation (s.d.) of 1. Separate regression and standardization analysis 
were performed for men and women, thereby adjusting for sex. No outliers of the adjusted 
values were detected or excluded based on the criteria >4 s.d. from the mean and at least 1 
s.d. from the nearest data point.
 Genetic correlation
In the bivariate linkage model, the phenotype covariance can be decomposed into genetic 
and environmental components, such that
where h12 and h22 are the heritabilities of trait 1 and trait 2, and ρg and ρe are the additive 
genetic and individual-specific environmental correlations between the two traits, 
respectively. In this study, the genetic correlation between CRP and BMI was estimated by 
gender using SOLAR 2.1.4 (http://www.sfbr.org/solar/index.html) (19).
 Primary linkage analysis
The identity-by-descent matrix for each pedigree was computed by GeneHunter (version 
2.0) (Whitehead Institute for Biomedical Research, Cambridge, MA) with multipoint 
approach (20). Bivariate linkage analyses were conducted for CRP and BMI for combined 
and gender specific samples utilizing maximum likelihood variance component methods 
implemented in the program SOLAR 2.1.2. In the bivariate linkage model in which a major 
locus and residual polygenic genetic effects influence two traits, the covariation of the two 
traits (Ω12) for each pedigree is given by:
where ρq, ρg, and ρe are the shared variances between the two traits due to the major gene, 
the residual genetic effects, and the individual-specific environmental effects, respectively. 
σq, σg, and σe, are the QTL specific genetic variance, the residual genetic variance, and 
individual-specific environmental variance, respectively. Π is a matrix whose elements (πqij) 
provide the probability that individuals i and j are identity-by-descent at a quantitative trait 
locus which is linked to a genetic marker locus, Φ is the kinship matrix, and I is an identity 
matrix. The lod score of two degrees of freedom (2-d.f.) was produced by comparing 
likelihood for the linkage model in which pq was estimated to the likelihood for the 
restricted model in which pq was equal to 0 (ref. 20). The 2-d.f. effective bivariate LOD 
score is then divided by 2ln10 to convert to the 1-d.f. effective LOD score, which is 
equivalent to the univariate LOD score (21).
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The false discovery rate was used to measure the expected proportion of false positives 
among the total number of rejections of the null hypothesis (22). False discovery rate was 
estimated using the SAS package and the P value adjusted for false discovery rate was 
denoted here by “q” value.
 RESULTS
Table 1 presents the baseline characteristics for the participants genotyped in the NHLBI 
FHS and involved in the present study. The average age for whites was ~57 years in men and 
58 years in women. AAs were younger with average age of 51 and 54, respectively. Men had 
a lower mean concentration of CRP compared to women in both races, and had higher mean 
BMI in whites but lower mean BMI in AAs. Higher levels of CRP and BMI were observed 
in AAs. The significant covariate terms in stepwise multiple regression analyses stratified by 
race and sex are provided in Table 2.
The heritabilities of CRP and BMI and their genetic and environmental correlations in 
gender specific samples are given in Table 3. In whites, BMI exhibited moderate 
heritabilities, which were higher than those of CRP in men, women, and the combined 
sample. AAs had relative high heritabilities for BMI in both gender specific samples and the 
combined sample, and moderate to high heritabilities for CRP. We observed significant 
gender effect on the genetic correlation between CRP and BMI, which was high in women 
(0.54 for whites and 0.53 for AAs) but low and nonsignificant in men (0.18 for whites and 
0.39 for AAs). Compared to the estimates of whites, the heritabilities in AAs were generally 
higher but with much larger standard deviation due to the small sample size.
Univariate and bivariate LOD scores and the approximate locations of bivariate peaks ≥1.5 
from genome scan of CRP and BMI were shown in Table 4. We detected a maximum 
bivariate LOD score of 3.86 at ~139 cM on chromosome 12 in white women (P = 0.00003, q 
= 0.005, near marker GATA4H01, Figure 1). Additional suggestive linkage evidence 
associated with CRP and BMI in white women was found at the position 44 cM on 
chromosome 19 with lod score of 2.19 (P = 0.0008, q = 0.065, near marker GATA66B04). 
Both linkage peaks were substantially higher than their respective univariate lods at the same 
chromosome location for each trait. Though CRP and BMI shared more genetic determines 
in AAs, the strongest linkage signal (LOD = 2.76) was obtained in men localized at 47 cM 
from p-telomere (p-ter) on chromosome 5 with nonsignificant q value (P = 0.0002, q = 
0.100, near marker GATA7C06). A second peak was observed on chromosome 12 at the 
region 8 cM p-ter (P = 0.0003, q = 0.10, near marker GATA4H03). In addition, a peak in AA 
men with an lod score of 1.89 on chromosome 12 at 158 cM from p-ter (P = 0.0016, q = 
0.105, near marker ATA29A06) located ~20 cM from the strongest signal detected on 
chromosome 12q24.2–24.3 in white women.
 DISCUSSION
Many publications have reported genome scans on BMI or other obesity-related phenotypes 
with linkage signals spread overall 22 autosomal chromosomes (see 23 for review). Only a 
few studies have carried out a linkage analyses for CRP (11,15,24). The aim of present study 
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was to conduct the first bivariate genome-wide linkage analysis on BMI and CRP to identify 
loci linked to both traits. BMI and CRP were both found to be heritable moderately in 
whites, and moderately to highly in AAs. They were also genetically correlated among 
women and combined sample in both races, but not in men. In addition, two chromosomal 
loci were identified as regions of interest that may harbor genes with pleiotropic effects on 
BMI and CRP in white women.
In the present analysis, the most significant bivariate linkage region to BMI and CRP was 
found in white women at ~139 cM on chromosome 12 (LOD = 3.86, P = 0.00003, q = 
0.005). This linkage signal coincides with a suggestive signal for abdominal subcutaneous 
fat (LOD = 2.9) from 156 white families in the Québec Family Study (25). The 1 LOD unit 
support interval of the signal spanned 24 cM, from 122 to 147 cM (12q24.1–12q24.3). The 
region has been linked to percent body fat (LOD = 4.08) and BMI (LOD = 3.57) measured 
by bioelectric impedance in 1,297 individuals from 260 white families (26). Two other 
genome scans for obesity have also identified linkage evidence within this region in AA 
populations. The first of these mapped percent energy from FAT to 12q24.21 (LOD = 2.9) in 
313 subjects from 126 families of the Health, Risk Factors, Exercise Training and Genetics 
(HERITAGE) Family Study (27), and the second associated BMI with markers D12S1638 
on 12q24.33 (Lod = 1.94) in 277 subjects from 59 pedigrees ascertained for probands with 
obstructive sleep apnea (28). One recent study reported bivariate linkage analysis for CRP 
and fibrinogen in hypertensive sibships (15). A region was identified at 12q24 (152 cM) with 
LOD of 3.43 in AAs, which is near our finding. Our present study also demonstrated 
suggestive evidence of linkage for BMI and CRP on chromosome 12 (LOD = 1.89, 158 cM, 
P = 0.0016, q = 0.105) in AA men.
A second suggestive QTL was detected in the current study among women at 44 cM on 
chromosome 19 (LOD = 2.19, P = 0.0008, q = 0.065). This peak overlaps with previously 
identified linkage QTLs for childhood obesity in white populations. A genome-wide linkage 
analysis conducted in 506 subjects from 115 multiplex French white families with at least 
one child with a BMI ≥ 95th percentile revealed evidence of linkage (LOD = 2.13) at 43.3 
cM on chromosome 19 for age of adiposity rebound, which corresponds to the beginning of 
the second rise in childhood adiposity (29). Another genome scan for BMI conducted in 369 
subjects from 89 German families with ≥2 obese children and/or adolescents, reported an 
LOD of 1.97 at 53 cM on this chromosome (30).
Our linkage results support the presence of loci influencing susceptibility to obesity and 
inflammation in white women. The 1 LOD unit support interval of the QTL on chromosome 
12 (12q24.2–24.3) harbors an interesting candidate gene, AMP-activated protein kinase β-1 
(AMPK-β1, 12q24.1), whose product is a regulatory subunit of AMPK. Activation of 
hypothalamic AMPK was shown to block leptin’s effects on food intake and body weight 
(31). Recent findings also suggest that AMPK activation could influence CRP production by 
modulating adipocyte secretion of interleukin-6 (ref. 32). The 1.0-LOD support interval of 
the suggestive linkage signal on chromosome 19 (19p13.2–19q13.12) includes the resistin 
gene (RETN, 19p13.2). Resistin, an adipocyte-secreted hormone, was originally described 
as the link between obesity and insulin resistance (33). It also has been shown in subjects 
with type 2 diabetes that increased serum resistin is related to the elevated CRP (34).
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A large number of published genome-wide scans support the hypothesis that chromosome 
12q24 might harbor a gene increasing susceptibility to type 2 diabetes. In a study involving 
an extended pedigree with late-onset Type 2 diabetes, Shaw et al. have reported significant 
linkage (LOD = 3.65) on 12q24 at recombination fraction 0.0008, telomeric to marker 
D12S321 (ref. 35). Lindgren et al. reported a multipoint LOD score of 1.80 for this region, 
in a sample consisting of 58 Finnish families with 229 type 2 diabetes subjects (36). Linkage 
to type 2 diabetes on chromosome 12q24 has also been reported in the Africa America 
Diabetes Mellitus (AADM) Study (LOD score 1.92 at 131 cM near marker D12S2070) (ref. 
37). It is well established that the relative risk of developing type 2 diabetes mellitus 
increases with increasing BMI. Recent studies also revealed that subclinical chromic low-
grade inflammation might play an important role in the pathogenesis of insulin resistance 
and type 2 diabetes (38). CRP was found related to the degree of insulin resistance and the 
development of diabetes independent of obesity (39) and other well known risk factors, with 
a dose-dependent correlation (40). In addition, some antidiabetic agents have been shown to 
reduce the levels of CRP and other inflammatory markers in serum. Conversely, anti-
inflammatory drugs have also been reported to improve glucose tolerance (41). Though the 
mechanism needs to be explored, our finding on chromosome 12q24 provided the further 
evidence for the potential link between obesity, inflammation, and type 2 diabetes 
demonstrated by recent epidemiological and clinical studies.
Few studies have examined sex differences for the associations between body composition 
and inflammatory markers. In present study, we observed considerably stronger genetic 
associations between CRP and BMI in women than in men. Our observation is consistent 
with results from the KORA Group (42). Their results showed that markers of inflammation 
were more strongly associated with measures of obesity in women than in men, and this was 
especially evident for CRP. Physiological differences might explain these findings. First, 
women have a higher total fat mass and larger subcutaneous fat deposits, while men have 
larger intra-abdominal fat deposits (43,44). Because anthropometric measures, such as BMI, 
predicted a smaller percentage of the total variance in intra-abdominal fat area for men than 
for women (44), which may in turn lead to the weaker association observed between 
measures of obesity and markers of inflammation in men. In addition, sex hormones could 
influence levels of inflammatory markers including CRP differently in men and women. In 
the present study, women had higher levels of CRP and lower BMI than men (Table 1).
One limitation of our study is that we did not have equal representation of AA and white 
individuals. Therefore, our study was underpowered to estimate the genetic correlation and 
detect linkage signals in AAs, particularly in gender specific groups. In addition, though we 
detected one region of significant linkage and one region of suggestive linkage for CRP and 
BMI in bivariate analysis in the present study, several challenges of genetic components 
underlying complex traits are existed in linkage analysis in terms of discovering genes, 
including locus heterogeneity, epistasis, low penetrance, variable expressivity. Even if 
statistically significant evidence of linkage is obtained, the region of linkage extensive is 
usually exceeding 10 cM and the candidate gene studies are still required to detect the causal 
gene or genes within this region. Recently, the genome-wide association study by 
genotyping single-nucleotide polymorphisms in a large population of cases and controls or 
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families has become a more powerful and efficient method to identify disease causative 
genes, especially for complex diseases.
In conclusion, we identified a genomic region 12q24.2–24.3 with significant bivariate 
linkage evidence for inflammatory biomarker CRP and obesity in white women. These 
findings not only reinforce the significant relationship between inflammation response and 
the development of obesity, but also reveal strong genetic evidence suggesting that common 
genes may influence both sets of traits. Follow-up study can be conducted by genotyping 
single-nucleotide polymorphisms in attractive candidate genes within these regions. The 
current trend is to use genome-wide association methods, which may be more powerful for 
identifying genes for common diseases and complex traits. The investigation can be 
extended to other systemic inflammatory biomarkers, such as interleukin-6 and monocyte 
chemoattractant protein-1, to explore additional insights into the pathogenesis of obesity.
 Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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